P1 (Tikun Olam USA)

P1 is a botanical cannabis formulation developed by Tikun Olam USA, specifically designed for the management of pain and inflammation. As a standardized cannabis-based product, it is part of Tikun Olam's research-driven pipeline aimed at providing evidence-based therapeutic options. The formulation leverages the pharmacological properties of phytocannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which are derived from proprietary cannabis strains. Its therapeutic effect is mediated through the endocannabinoid system, where it acts as an agonist at cannabinoid receptors (CB1 and CB2). This interaction modulates pain signaling in the central nervous system and reduces the production of pro-inflammatory cytokines, thereby providing analgesic and anti-inflammatory relief. P1 is intended for use in clinical settings to address chronic pain and inflammatory conditions through standardized dosing and delivery.

Brand names

P1P-1P 1